A rapidly growing biotechnology company that is pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology. Our partner is committed to developing a differentiated class of therapeutics for oncology indications and more.

This critical hire provided medical and scientific leadership to programs across the portfolio aimed at developing several highly novel peptide therapeutics. This Physician led early development planning and study conduct while thinking strategically during key interactions at the highest leadership levels. They helped drive program activities and guided program teams. They also supported strategic portfolio planning including toxin-conjugate and immune agonist therapeutics.